Ghrelin-receptor research · Evidence review
Ipamorelin
What did the human trial actually find?
A human trial exists, but its surgical setting and negative efficacy result matter when assessing wellness claims.
What was actually studied
Hospital patients recovering from bowel surgery received intravenous ipamorelin or placebo.
What the paper found
- The selected trial found no statistically significant improvement in its key or secondary efficacy analyses.
Where the claim goes beyond the evidence
- This was a small postoperative study, not a test of muscle gain, sleep, or anti-aging.
- Its findings do not establish benefits or safety for other routes or prolonged use.
Safety context
FDA flags immune-response concerns and serious adverse events reported during intravenous use; other injection routes lack adequate safety information.
A research summary cannot establish that a product is suitable for you. Clinical decisions belong with a qualified health professional.
Read the original sources
- Original research — PubMed abstractProspective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. ↗
- FDA safety informationCertain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks ↗